P/B
—
Alps
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
$54.6M
Market Cap • 10/23/2026
2024
(2 years)
Founded
2025
(1 year ago)
IPO
NASDAQ
Listing Exchange
Malaysia
Country
Valuation
P/S
11,2
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
54,6M
EV
54,5M
EV/Revenue
11,2
EV/EBITDA
-60,5
EV/EBIT
-26,9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-5,7%
Total Yield
-5,7%
Payout
0%
Retained Earnings
-13,2M
Profitability
Gross Margin
32,1%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
1,2%
Capex/D&A
5%
Capex/OCF
-2,2%
SBC/OCF
—
% PPE
38,7%
% Goodwill
0%
ROE
96%
ROIC
—
Leverage
N.D./EBITDA
0,1
Debt/Equity
0%
Current Ratio
0,4
Quick Ratio
0,2
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!